Abstract:The mechanism by which ginsenosides from Panax quinquefolium L. transform into rare saponins by different processing methods and their antitumour effects have yet to be fully elucidated. Our study aimed to detect the effect of amino acids and processing methods on the conversion of ginsenosides in American ginseng to rare ginsenosides, using 8 monomeric ginsenosides as substrates to discuss the reaction pathway and mechanism. S180 tumour-bearing mice were established to study the antitumour effects of American ginseng total saponins (AGS-Q) or American ginseng total saponins after transformation (AGS-H) synergistic CTX. The results showed that aspartic acid was the best catalyst, and the thermal extraction method had the best effect. Under the optimal conditions, including a reaction temperature of 110°C, an aspartic acid concentration of 5%, a reaction time of 2.5 h and a liquid-solid ratio of 30 mL/g, the highest conversion of Rk 1 and Rg 5 was 6.58 ± 0.11 mg/g and 3.74 ± 0.05 mg/g, respectively. In the reaction pathway, the diol group saponins participated in the transformation process, and the triol group saponins basically did not participate in the transformation process. AGS-Q or AGS-H synergistic CTX, or AGS-H synergistic CTX/2 could significantly increase the tumour inhibition rate, spleen index and white blood cell count, had a significant upregulation effect on IL-2 and IL-10 immune cytokines; significantly restored the ratio of CD4 + /CD8 + ; and significantly inhibited the level of CD4 + CD25 + . AGS-Q or AGS-H synergistic with CTX or CTX/2 can significantly upregulate the expression of Bax and cleaved-Caspase-3 and inhibit the expression of antiapoptotic protein Bcl-2. AGS synergistic CTX in the treatment of S180 tumour-bearing mice can improve the efficacy and reduce toxicity.

Rapid preparation of rare ginsenosides by acid transformation and their structure-activity relationships against cancer cells

Isolation, Synthesis and Structures of Cytotoxic Ginsenoside Derivatives

[Preparation and Isolation on the Rare Ginsenoside Derivatives with Anti-Cancer Activity].

Structure of Acid Hydrolysate of Total Ginsenosides and Their Cytotoxic Activity

Preparation and bioactivity of the rare ginsenosides Rg3 and Rh2: An updated review

Biotransformation of ginsenoside Rb1 and Rd to four rare ginsenosides and evaluation of their anti-melanogenic effects

Advancements in Enzymatic Biotransformation and Bioactivities of Rare Ginsenosides：a Review

Isolation, Synthesis and Structures of Ginsenoside Derivatives and Their Anti-Tumor Bioactivity

Transformation Mechanism of Rare Ginsenosides in American Ginseng by Different Processing Methods and Antitumour Effects

[Discussion on Correlation Between Preparation, in Vivo Conversion Process and Potential Structure-Activity Relationship of Ginsenoside].

Enzymatic Preparation of 20(S, R)-protopanaxadiol by Transformation of 20(S, R)-Rg3 from Black Ginseng

Transformation of Bioactive Compounds by Fusarium Sacchari Fungus Isolated from the Soil-Cultivated Ginseng

In Vitro Study of the Relationship Between the Structure of Ginsenoside and Its Antioxidative or Prooxidative Activity in Free Radical Induced Hemolysis of Human Erythrocytes.

Ginsenosides As Anticancer Agents: in Vitro and in Vivo Activities, Structure-Activity Relationships, and Molecular Mechanisms of Action

Targeted Preparation of Six Rare Ginsenosides Using Two Β-Glucosidases from Bifidobacterium Adolescentis

Highly Efficient Production of Diverse Rare Ginsenosides Using Combinatorial Biotechnology.

Production of rare ginsenosides by biotransformation of Panax notoginseng saponins using Aspergillus fumigatus

Semisynthesis and bioactive evaluation of oxidized products from 20(S)-ginsenoside Rg3, Rh2, protopanaxadiol (PPD) and their 20(R)-epimers as cytotoxic agents

Synthesis and anti-cancer cell activity of pseudo-ginsenoside Rh2

Biocatalytic strategies in producing ginsenoside by glycosidase-a review

Enzymatic Transformation of Panax Notoginseng Stem and Leaves for Preparation Anti-Tumor Activity Constituents